EED expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.236800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.359800E-01
Normal-vs-Stage2
4.485000E-01
Normal-vs-Stage3
1.388410E-01
Normal-vs-Stage4
3.140800E-01
Stage1-vs-Stage2
7.577200E-01
Stage1-vs-Stage3
2.336400E-01
Stage1-vs-Stage4
9.678000E-01
Stage2-vs-Stage3
6.422400E-02
Stage2-vs-Stage4
8.361400E-01
Stage3-vs-Stage4
2.340000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.276200E-01
Normal-vs-AfricanAmerican
4.892600E-01
Normal-vs-Asian
3.724200E-01
Caucasian-vs-AfricanAmerican
7.061400E-01
Caucasian-vs-Asian
4.958600E-01
AfricanAmerican-vs-Asian
3.717600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.392200E-01
Normal-vs-Female
4.107200E-01
Male-vs-Female
5.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.048000E-01
Normal-vs-Age(41-60Yrs)
4.715400E-01
Normal-vs-Age(61-80Yrs)
6.179700E-02
Normal-vs-Age(81-100Yrs)
4.189200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.792000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.446200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.177400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.165800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.738400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.790600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.672200E-01
Normal-vs-Daily Drinker
9.736100E-02
Normal-vs-Weekly Drinker
6.633600E-02
Normal-vs-Occasional Drinker
4.730400E-01
Normal-vs-Social Drinker
4.228600E-01
Non Drinker-vs-Daily Drinker
7.579400E-01
Non Drinker-vs-Weekly Drinker
7.997000E-01
Non Drinker-vs-Occasional Drinker
1.700820E-01
Non Drinker-vs-Social Drinker
5.422000E-01
Daily Drinker-vs-Weekly Drinker
6.511400E-01
Daily Drinker-vs-Occasional Drinker
3.724200E-01
Daily Drinker-vs-Social Drinker
7.974000E-01
Weekly Drinker-vs-Occasional Drinker
1.444160E-01
Weekly Drinker-vs-Social Drinker
4.676400E-01
Occasional Drinker-vs-Social Drinker
5.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.062590E-01
Normal-vs-Grade 2
4.521300E-03
Normal-vs-Grade 3
4.577700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.116810E-01
Grade 1-vs-Grade 3
2.612100E-02
Grade 1-vs-Grade 4
1.062590E-01
Grade 2-vs-Grade 3
3.077600E-01
Grade 2-vs-Grade 4
4.521300E-03
Grade 3-vs-Grade 4
4.577700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.493800E-02
Normal-vs-NonDiabetic
3.892400E-01
Diabetic-vs-NonDiabetic
9.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.289600E-01
Normal-vs-NoPancreatitis
3.909000E-01
Pancreatitis-vs-NoPancreatitis
6.888400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.197400E-01
Normal-vs-N1
4.359400E-01
N0-vs-N1
7.398200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.541000E-01
Normal-vs-TP53-NonMutant
1.683620E-01
TP53-Mutant-vs-TP53-NonMutant
1.725420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
